[1] World Health Organization. Global tuberculosis report 2020 [Internet]. Vol. 1, Geneva: World Health Organization. 2020 [cited 2021 Feb 2]. p. 1–8. Available from: https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf
[2] Ralph AP, Ardian M, Wiguna A, Maguire GP, Becker NG, Drogumuller G, et al. A simple, valid, numerical score for grading chest x-ray severity in adult smear-positive pulmonary tuberculosis. Thorax. 2010 Oct;65(10):863–9. https://doi.org/10.1136/thx.2010.136242.
[3] American Thoracic Society. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis. 2000;161 (4Pt1):1376–95. https://doi.org/doi: 10.1164/ajrccm.161.4.16141.
[4] Horita N, Miyazawa N, Yoshiyama T, Kojima R, Omori N, Inoue M, et al. The presence of pretreatment cavitations and the bacterial load on smears predict tuberculosis infectivity negative conversion judged on sputum smear or culture. Intern Med. 2012;51(24):3367–72. https://doi.org/DOI: 10.2169/internalmedicine.51.8585.
[5] Bisognin F, Amodio F, Lombardi G, Reggiani MLB, Vanino E, Attard L, et al. Predictors of time to sputum smear conversion in patients with pulmonary tuberculosis under treatment. New Microbiol. 2019;42(3):171–5.
[6] Kanda R, Nagao T, Van Tho N, Ogawa E, Murakami Y, Osawa M, et al. Factors affecting time to sputum culture conversion in adults with pulmonary tuberculosis: A historical cohort study without censored cases. PLoS One. 2015;10(11):1–9. https://doi.org/10.1371/journal.pone.0142607.
[7] Caetano Mota P, Carvalho A, Valente I, Braga R, Duarte R. Predictors of delayed sputum smear and culture conversion among a Portuguese population with pulmonary tuberculosis. Rev Port Pneumol. 2012;18(2):72–9. https://doi.org/10.1016/j.rppneu.2011.12.005.
[8] Mi F, Tan S, Liang L, Harries AD, Hinderaker SG, Lin Y, et al. Diabetes mellitus and tuberculosis: pattern of tuberculosis, two-month smear conversion and treatment outcomes in Guangzhou, China. Trop Med Int Health. 2013 Nov;18(11):1379–85. https://doi.org/10.1111/tmi.12198.
[9] Singla R, Osman MM, Khan N, Al-Sharif N, Al-Sayegh MO, Shaikh MA. Factors predicting persistent sputum smear positivity among pulmonary tuberculosis patients 2 months after treatment. Int J Tuberc Lung Dis. 2003;7(1):58–64.
[10] Visser ME, Stead MC, Walzl G, Warren R, Schomaker M, Grewal HMS, et al. Baseline predictors of sputum culture conversion in pulmonary tuberculosis: Importance of cavities, smoking, time to detection and w-beijing genotype. PLoS One. 2012;7(1). https://doi.org/10.1371/journal.pone.0029588.
[11] Tostmann A, Kik S V., Kalisvaart NA, Sebek MM, Verver S, Boeree MJ, et al. Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands. Clin Infect Dis. 2008;47(9):1135–42. https://doi.org/10.1086/591974.
[12] Su W-J, Feng J-Y, Chiu Y-C, Huang S-F, Lee Y-C. Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis. Eur Respir J. 2011 Feb;37(2):376–83. https://doi.org/10.1183/09031936.00007410.
[13] Lawn SD, Edwards D, Wood R. Tuberculosis transmission from patients with smear-negative pulmonary tuberculosis in sub-Saharan Africa. Clin Infect Dis. 2009;48(4):496–7. https://doi.org/10.1086/596550.
[14] Al-Moamary MS, Black W, Bessuille E, Elwood RK, Vedal S. The significance of the persistent presence of acid-fast bacilli in sputum smears in pulmonary tuberculosis. Chest. 1999 Sep;116(3):726–31.
[15] Chien J-Y, Chen Y-T, Shu C-C, Lee J-J, Wang J-Y, Yu C-J, et al. Outcome correlation of smear-positivity for acid-fast bacilli at the fifth month of treatment in non-multidrug-resistant TB. Chest. 2013 Jun;143(6):1725–32. https://doi.org/10.1378/chest.12-2051.
[16] Fitzwater SP, Caviedes L, Gilman RH, Coronel J, LaChira D, Salazar C, et al. Prolonged infectiousness of tuberculosis patients in a directly observed therapy short-course program with standardized therapy. Clin Infect Dis. 2010;51(4):371–8. https://doi.org/10.1086/655127.
[17] World Health Organization. WHO Guidelines on Tuberculosis Infection Prevention and Control [Internet]. Vol. 82, Gesundheitswesen. 2020 [cited 2021 Feb 2]. p. 885–9. https://doi.org/10.1055/a-1241-4321. Available from: https://apps.who.int/iris/bitstream/handle/10665/311259/9789241550512-eng.pdf?ua=1&ua=1
[18] González-Martn J, Garca-Garca JM, Anibarro L, Vidal R, Esteban J, Blanquer R, et al. Consensus document on the diagnosis, treatment and prevention of tuberculosis. Enferm Infecc Microbiol Clin. 2010;28(5):1–20. https://doi.org/10.1016/j.eimc.2010.02.006.
[19] National Institute for Health and Care Excellence (NICE). Tuberculosis (NICE guideline 33) [Internet]. 2020 [cited 2021 Feb 2]. Available from: www.nice.org.uk/guidance/ng33
[20] Fortún J, Martín-Dávila P, Molina A, Navas E, Hermida JM, Cobo J, et al. Sputum conversion among patients with pulmonary tuberculosis: Are there implications for removal of respiratory isolation? J Antimicrob Chemother. 2007;59(4):794–8. https://doi.org/10.1093/jac/dkm025.
[21] Musteikienė G, Miliauskas S, Zaveckienė J, Žemaitis M, Vitkauskienė A. Factors associated with sputum culture conversion in patients with pulmonary tuberculosis. Med. 2017;53(6):386–93. https://doi.org/10.1016/j.medici.2018.01.005.
[22] Hatsuda K, Takeuchi M, Ogata K, Sasaki Y, Kagawa T, Nakatsuji H, et al. The impact of nutritional state on the duration of sputum positivity of Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2015;19(11):1369–75. https://doi.org/10.5588/ijtld.14.0963.
[23] Telzak EE, Fazal BA, Turett GS, Justman JE, Blum S, Iseman MD. Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis [4] (multiple letters). Clin Infect Dis. 1998;26(3):775–6. https://doi.org/10.1086/517133.
[24] Domínguez-Castellano A, Muniain MA, Rodriguez-Baño J, Garcia M, Rios MJ, Galvez J, et al. Factors associated with time to sputum smear conversion in active pulmonary tuberculosis. Int J Tuberc Lung Dis. 2003;7(5):432–8.
[25] Chedid C, Kokhreidze E, Tukvadze N, Banu S, Uddin MKM, Biswas S, et al. Association of baseline white blood cell counts with tuberculosis treatment outcome: a prospective multicentered cohort study. Int J Infect Dis. 2020;100:199–206. https://doi.org/10.1016/j.ijid.2020.09.017.
[26] Han Y, Kim SJ, Lee SH, Sim YS, Ryu YJ, Chang JH, et al. High blood neutrophil-lymphocyte ratio associated with poor outcomes in miliary tuberculosis. J Thorac Dis. 2018;10(1):339–46. https://doi.org/10.21037/jtd.2017.12.65.
[27] Unsematham S, Kateruttanakul P. Factors predicting sputum smear conversion and treatment outcomes in new smear-positive pulmonary tuberculosis. J Med Assoc Thai. 2013 Jun;96(6):644–9.
[28] Ors F, Deniz O, Bozlar U, Gumus S, Tasar M, Tozkoparan E, et al. High-resolution CT findings in patients with pulmonary tuberculosis: Correlation with the degree of smear positivity. J Thorac Imaging. 2007;22(2):154–9. https://doi.org/10.1097/01.rti.0000213590.29472.ce.